KORYS
KORYS and the 158 companies it controls according to the LEI register and the annual accounts: the structure, the figures, each company's health and where the risk sits.
Sum of the filed annual accounts of 150 of the 157 Belgian companies (fiscal years 2024-2026). Not a consolidation: receivables, participations and sales between group companies are not eliminated, so they count.
Group risk
How healthy the group's Belgian companies are, and where the risk sits. A weak subsidiary can cost the parent money, and the other way round.
- The parent itself: KORYS, no verdict.
- 10 companies with negative equity: ZEEBOERDERIJ WESTDIEP (-€3.6m), Marlinks (-€987,098), GEO OST IMMO (-€542,596), DIODI (-€274,423), POINT CARRE FRANCHISE (-€263,816), VE Solar Energy 1 (-€4,547) and 4 more.
- 55 companies with a loss in the latest year: CoMarkt (-€19.2m), Bike Republic (-€5.3m), JIMS (-€5.3m), Virya Energy APAC (-€5.3m), PUUR (-€4.7m), SOLUCIOUS (-€4.5m) and 49 more.
- 9 companies no longer active in the register: ADISO, CODEVCO XVIII, DELDEN, Marlinks, POINT CARRE, ROECOL and 3 more.
- 35.3% of the added-up total assets sits in one company: Colruyt Group.
- 15.5% of the added-up total assets sits at companies with an elevated or high risk.
Group structure
Who consolidates whom according to the LEI register, completed with who holds more than half of the shares according to the annual accounts. Both mean control.
- KORYS10 subsidiariesNo verdict€2.78bn €2.54bn 2025
- Colruyt Group20 subsidiariesHealthy · 69€8.64bn €6.53bn 2025
- Ahara1 subsidiaryHealthy · 62€2.58bn €2.58bn 2025
- Colruyt Food Retail24 subsidiariesElevated · 43€3.15bn €896.2m 2025
- Fair · 45€10.8m €1.5m 2026
- Elevated · 59€1.1m €939,420 2025
- Elevated · 31€71.0m €3.1m 2026
- Elevated · 35€7.5m €432,371 2025
- BUURTWINKELS OKAY1 subsidiaryElevated · 42€192.2m €38.5m 2025
- Fair · 56€3.7m €1.2m 2026
- Healthy · 73€61,500 €61,500 2025
- No verdict€64,257 €61,500 2025
- Fair · 46€701,777 €113,446 2026
- Elevated · 34€65.5m €20.9m 2025
- Healthy · 69€5.6m €3.6m 2025
- Fair · 49€5.1m €816,185 2025
- Healthy · 64€19.2m €10.0m 2025
- Healthy · 74€971,818 €790,182 2025
- No verdictno figures
- NORTHLANDT2 subsidiariesHealthy · 73€50.3m €49.4m 2025
- Elevated€10.7m €7.7m 2025
- Fair · 57€19.2m €6.1m 2025
- Fair · 58€477,053 €146,186 2025
- Fair · 47€787,130 €143,521 2026
- Healthy · 64€2.1m €2.0m 2025
- Healthy · 71€2.6m €1.1m 2025
- Fair · 59€104.7m €25.2m 2025
- Fair · 50€90.1m €36.5m 2025
- Healthy · 64€9.4m €9.4m 2026
- No verdict€62,684 €61,500 2025
- Elevated€64,219 €61,500 2025
- COLIM10 subsidiariesHealthy · 81€1.79bn €1.26bn 2025
- Healthy · 85€1.5m €1.1m 2025
- Avellana1 subsidiaryHealthy · 60€16.7m €870,065 2025
- Healthy · 84€2.6m €2.6m 2025
- Elevated€224,255 €219,959 2025
- Elevated · 59€2.9m €2.1m 2025
- Healthy · 69€3.2m €2.6m 2025
- Healthy · 69€3.6m €1.7m 2025
- Healthy · 96€652,457 €646,447 2025
- Healthy · 97€956,074 €771,962 2024
- Healthy · 88€420,328 €416,650 2025
- Healthy · 75€4.3m €3.7m 2025
- Darzana1 subsidiaryHealthy · 72€259.9m €244.0m 2025
- Bike Republic4 subsidiariesHigh risk · 12€35.1m €519,598 2025
- Fair · 59€808,903 €628,073 2025
- Elevated · 40€1.0m €374,760 2025
- Elevated · 44€2.0m €1.4m 2025
- Fair · 59€1.0m €532,730 2025
- Fair · 55€194.3m €92.6m 2024
- Fair · 51€2.6m €1.5m 2025
- Fair · 50€92.8m €37.8m 2025
- Healthy · 73€185.5m €55.1m 2025
- Healthy · 84€3.5m €1.7m 2026
- No verdictno figures
- No verdict€62,684 €61,500 2025
- Healthy · 75€5.1m €4.0m 2026
- Elevated€11.6m €10.5m 2025
- Sukhino4 subsidiariesHealthy · 63€295.9m €295.8m 2025
- DO Invest2 subsidiariesHealthy · 87€79.4m €68.1m 2025
- Fair · 58€32.0m €19.8m 2025
- JIMS Expansion1 subsidiaryHealthy · 60€23.0m €4.1m 2025
- No verdict€233,567 €165,138 2025
- Elevated · 59€907,167 €469,434 2025
- NEWPHARMA GROUP5 subsidiariesHealthy · 81€108.6m €86.3m 2026
- Fair · 59€1.5m €346,449 2026
- Fair · 54€1.3m €853,762 2026
- Elevated · 38€36.6m €1.8m 2026
- Fair · 59€56,516 €21,929 2026
- Healthy · 63€746,039 €508,048 2026
- Elevated€37,733 €37,733 2026
- THE FASHION SOCIETY27 subsidiariesHealthy · 61€137.3m €68.1m 2025
- No verdict€1.4m €753,990 2025
- Elevated · 33€3.5m €856,009 2025
- Healthy · 70€2.7m €1.6m 2025
- Healthy · 67€2.8m €1.8m 2025
- Elevated · 36€2.2m €680,943 2025
- Healthy · 78€3.6m €3.0m 2025
- Healthy · 73€10.8m €6.7m 2025
- Fair · 57€2.1m €800,876 2025
- Fair · 59€2.4m €1.0m 2025
- Elevated · 42€2.9m €1.4m 2025
- Healthy · 63€2.7m €1.0m 2026
- Elevated · 34€2.4m €698,124 2025
- Fair · 56€3.5m €1.4m 2025
- Elevated · 41€1.7m €670,264 2025
- Elevated€7.9m €4.8m 2025
- No verdict€2.0m -€263,816 2025
- Fair · 57€740,985 €305,102 2025
- Fair · 55€601,906 €154,934 2025
- Fair · 55€1.9m €1.4m 2025
- Fair · 59€3.0m €273,637 2026
- Healthy · 66€2.8m €1.6m 2025
- SOLISACO3 subsidiariesHealthy · 63€2.4m €1.2m 2025
- No verdict€532,397 €138,331 2023
- No verdict€1.1m €354,733 2023
- No verdict€1.2m €548,992 2023
- Healthy · 71€154,657 €95,367 2025
- Fair · 59€1.7m €686,927 2025
- Elevated€25.8m €1.4m 2025
- Healthy · 64€3.2m €1.7m 2025
- High risk · 23€3.7m €111,957 2025
- High risk · 18€2.2m -€3.6m 2025
- COLRUYT GROUP INDIA PRIVATE LIMITED
- Healthy · 87€10.9m €10.8m 2025
- Healthy · 87€5.4m €5.3m 2025
- Healthy · 87€9.4m €9.4m 2025
- Healthy · 75€255.6m €255.2m 2025
- KORYS INVESTMENTS5 subsidiariesNo verdict€1.11bn €1.11bn 2025
- D-DRINKS GROUP1 subsidiaryNo verdict€3.8m €3.8m 2025
- Fair · 56€4.4m €1.4m 2025
- Healthy Holding1 subsidiaryHealthy · 71€13.8m €10.7m 2024
- Healthy · 69€8.5m €3.4m 2024
- Innovative Food & Health Solutions2 subsidiariesNo verdict€41.0m €21.3m 2025
- Healthy · 78€8.8m €5.7m 2024
- Fair · 47€33,397 €3,064 2025
- Healthy · 67€53.8m €53.8m 2025
- Healthy · 69€163,504 €78,005 2025
- Healthy · 61€57.1m €50.0m 2025
- Healthy · 92€10.8m €10.7m 2025
- Virya Energy10 subsidiariesNo verdict€796.3m €717.3m 2024
- DIODI5 subsidiariesElevated · 44€4.0m -€274,423 2025
- Elevated · 41€750 -€4,250 2025
- Elevated · 41€287 -€4,013 2025
- Elevated · 40€953 -€4,547 2025
- Elevated · 40€341 -€4,359 2025
- Elevated · 40€255 -€4,245 2025
- Healthy · 68€16.4m €11.5m 2025
- Healthy · 78€36.9m €22.5m 2025
- Healthy · 73€409,511 €258,517 2025
- No verdict€89.3m €89.3m 2024
- Healthy · 73€136.6m €88.0m 2025
- Fair · 54€1.4m €352,664 2025
- AP ŻABICE 1 SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
High risk Elevated Healthy Fair No verdict Amounts: total assets and equity from the latest accounts.
Shared directors
Who sits on the boards of several group companies. This is where control over the group sits in practice.
-
37
-
26
- 25
-
18
-
17
-
15
- 5
- 4
- 4
- 3
-
2Colruyt Groupgroup company
-
2KORYS BUSINESS SERVICES I NVgroup company
-
2Korys Business Services II NVgroup company
-
2Korys Business Services III NVgroup company
- 2
- 2
- 2
Events in the group
Bankruptcies, director changes, capital changes and other publications of all Belgian group companies, over the last two years.
-
3 directors appointed, 1 director resigning, 3 reappointed
-
3 directors appointed, 2 directors resigning, 3 reappointed
-
3 directors appointed, 2 directors resigning, 3 reappointed
-
1 director appointed, 1 director resigning, 4 reappointed
-
3 directors appointed, 2 directors resigning, 3 reappointed
-
1 director appointed, 1 director resigning
-
3 directors appointed, 1 director resigning, 3 reappointed
-
3 directors appointed, 2 directors resigning, 3 reappointed
-
3 directors appointed, 2 directors resigning, 3 reappointed
-
3 directors appointed, 2 directors resigning, 3 reappointed
-
3 directors appointed, 2 directors resigning, 3 reappointed
-
3 directors appointed, 2 directors resigning, 3 reappointed
-
3 directors appointed, 2 directors resigning, 3 reappointed
-
3 directors appointed, 3 directors resigning, 3 reappointed
-
3 directors appointed, 2 directors resigning, 3 reappointed
-
3 directors appointed, 2 directors resigning, 3 reappointed
-
3 directors appointed, 1 director resigning, 3 reappointed
-
3 directors appointed, 2 directors resigning, 3 reappointed
-
3 directors appointed, 2 directors resigning, 3 reappointed
-
3 directors appointed, 2 directors resigning, 3 reappointed
-
3 directors appointed, 1 director resigning, 3 reappointed
-
3 directors appointed, 1 director resigning, 3 reappointed
-
3 directors appointed, 2 directors resigning, 3 reappointed
-
3 directors appointed, 2 directors resigning, 3 reappointed
-
3 directors appointed, 2 directors resigning, 3 reappointed
-
Fabrice Rosier appointed as day-to-day manager
-
1 director appointed, 1 director resigning
-
Capital increase of €2,298,665,271.92
-
1 director appointed, 1 director resigning
-
1 director appointed, 1 director resigning
The 30 most recent; each dossier shows its company's full timeline.
What is my exposure to this group?
The companies of this group you keep in your lists or follow, seen together.
Sign in to see which customers or suppliers from your lists belong to this group, and how they stand.
Where do these figures come from?
Completed with the annual accounts: a company of which another Belgian company holds more than half of the shares, by the list of holdings or the shareholder structure in its accounts, stands under that company, with the share. The register of ultimate beneficial owners (UBO) is not public.
The group's make-up comes from the LEI register (GLEIF): which company consolidates which other, directly or ultimately. A company whose link the register does not state is not listed here, even if it does belong to the group.
The amounts are those of the annual accounts each Belgian company filed with the National Bank, added up without consolidation. The verdict per company is that of its dossier on Checked.be. Everything is updated every night.
Updated on 28-09-2026